ANTXR1
Basic information
Region (hg38): 2:69013176-69249327
Links
Phenotypes
GenCC
Source:
- GAPO syndrome (Strong), mode of inheritance: AR
- capillary infantile hemangioma (Limited), mode of inheritance: AD
- GAPO syndrome (Supportive), mode of inheritance: AR
- GAPO syndrome (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Hemangioma, capillary infantile, susceptibility to; Growth retardation, alopecia, pseudoanodontia, and optic atrophy (GAPO syndrome) | AD/AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Dental; Dermatologic; Musculoskeletal; Ophthalmologic | 9180938; 9298746; 18931684; 19367160; 23602711 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ANTXR1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | 17 | ||||
missense | 54 | 60 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 1 | 1 | 1 | 4 | |
non coding | 55 | 64 | ||||
Total | 0 | 6 | 55 | 21 | 63 |
Variants in ANTXR1
This is a list of pathogenic ClinVar variants found in the ANTXR1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-69013206-G-A | Benign (May 20, 2021) | |||
2-69013211-G-T | Benign (May 20, 2021) | |||
2-69013458-G-A | Benign (May 20, 2021) | |||
2-69013512-G-A | Inborn genetic diseases | Uncertain significance (Apr 20, 2024) | ||
2-69013517-G-A | ANTXR1-related disorder | Benign/Likely benign (Jan 20, 2024) | ||
2-69013519-G-A | ANTXR1-related disorder | Benign (Jan 02, 2024) | ||
2-69013554-G-A | Inborn genetic diseases | Uncertain significance (May 17, 2023) | ||
2-69013576-C-T | Inborn genetic diseases | Uncertain significance (Aug 17, 2023) | ||
2-69013579-G-T | GAPO syndrome | Uncertain significance (Dec 13, 2018) | ||
2-69013599-G-A | Inborn genetic diseases | Uncertain significance (Apr 13, 2022) | ||
2-69013600-A-T | Inborn genetic diseases | Uncertain significance (Apr 13, 2022) | ||
2-69013632-C-G | Inborn genetic diseases | Uncertain significance (Mar 01, 2024) | ||
2-69013668-G-T | Likely benign (Nov 25, 2022) | |||
2-69013669-T-TC | Benign (Jan 15, 2024) | |||
2-69013740-G-C | GAPO syndrome | Benign (Dec 05, 2021) | ||
2-69039896-A-T | Benign (May 10, 2021) | |||
2-69040002-G-A | GAPO syndrome | Benign (Dec 05, 2021) | ||
2-69040036-T-C | Likely benign (Dec 31, 2022) | |||
2-69040135-T-G | Likely benign (Feb 01, 2023) | |||
2-69040172-T-C | Benign (May 20, 2021) | |||
2-69040196-A-G | GAPO syndrome | Benign (Dec 05, 2021) | ||
2-69044779-C-T | GAPO syndrome | Pathogenic (May 02, 2013) | ||
2-69044780-G-A | Inborn genetic diseases | Uncertain significance (Feb 17, 2024) | ||
2-69044961-G-A | Benign (May 11, 2021) | |||
2-69044974-G-A | Benign (May 10, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ANTXR1 | protein_coding | protein_coding | ENST00000303714 | 18 | 236150 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.986 | 0.0137 | 125734 | 0 | 14 | 125748 | 0.0000557 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.52 | 240 | 316 | 0.759 | 0.0000187 | 3638 |
Missense in Polyphen | 78 | 132.44 | 0.58893 | 1543 | ||
Synonymous | -1.74 | 142 | 118 | 1.20 | 0.00000745 | 1103 |
Loss of Function | 4.70 | 5 | 35.0 | 0.143 | 0.00000186 | 406 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000275 | 0.000275 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000530 | 0.0000527 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role in cell attachment and migration. Interacts with extracellular matrix proteins and with the actin cytoskeleton. Mediates adhesion of cells to type 1 collagen and gelatin, reorganization of the actin cytoskeleton and promotes cell spreading. Plays a role in the angiogenic response of cultured umbilical vein endothelial cells. {ECO:0000269|PubMed:15777794, ECO:0000269|PubMed:16762926}.;
- Disease
- DISEASE: Hemangioma, capillary infantile (HCI) [MIM:602089]: A condition characterized by dull red, firm, dome-shaped hemangiomas, sharply demarcated from surrounding skin, usually presenting at birth or occurring within the first two or three months of life. They result from highly proliferative, localized growth of capillary endothelium and generally undergo regression and involution without scarring. {ECO:0000269|PubMed:18931684}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: GAPO syndrome (GAPO) [MIM:230740]: A disease characterized by growth retardation, alopecia, failure of tooth eruption, and progressive optic atrophy in some patients. {ECO:0000269|PubMed:23602711}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- NOD-like receptor signaling pathway - Homo sapiens (human);Disease;Uptake and actions of bacterial toxins;Uptake and function of anthrax toxins;Infectious disease;EGFR1;Cellular roles of Anthrax toxin
(Consensus)
Recessive Scores
- pRec
- 0.136
Intolerance Scores
- loftool
- 0.156
- rvis_EVS
- -0.91
- rvis_percentile_EVS
- 10.03
Haploinsufficiency Scores
- pHI
- 0.520
- hipred
- Y
- hipred_score
- 0.851
- ghis
- 0.661
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.545
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Antxr1
- Phenotype
- endocrine/exocrine gland phenotype; growth/size/body region phenotype; cellular phenotype; craniofacial phenotype; neoplasm; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); skeleton phenotype;
Gene ontology
- Biological process
- blood vessel development;reproductive process;actin cytoskeleton reorganization;substrate adhesion-dependent cell spreading;negative regulation of extracellular matrix assembly;toxin transport;positive regulation of metallopeptidase activity
- Cellular component
- plasma membrane;external side of plasma membrane;cell surface;endosome membrane;integral component of membrane;lamellipodium membrane;filopodium membrane
- Molecular function
- transmembrane signaling receptor activity;protein binding;collagen binding;metal ion binding;actin filament binding